Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 authorising a change of the conditions of use of the novel food 'trans-resveratrol' under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

The measure changes the conditions of use of the novel food 'trans-resveratrol' by removing the specific delivery formats, capsule or tablet form, as the only allowed forms of the food supplements containing the novel food 'trans-resveratrol' as listed in the Union list. Thus, the novel food will be authorised for use in any form of food supplements at the previously authorised maximum level.